284 related articles for article (PubMed ID: 27322692)
1. Seroprevalence of Anti-Chikungunya Virus Antibodies in Children and Adults in Managua, Nicaragua, After the First Chikungunya Epidemic, 2014-2015.
Kuan G; Ramirez S; Gresh L; Ojeda S; Melendez M; Sanchez N; Collado D; Garcia N; Mercado JC; Gordon A; Balmaseda A; Harris E
PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004773. PubMed ID: 27322692
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological Evidence for Lineage-Specific Differences in the Risk of Inapparent Chikungunya Virus Infection.
Bustos Carrillo F; Collado D; Sanchez N; Ojeda S; Lopez Mercado B; Burger-Calderon R; Gresh L; Gordon A; Balmaseda A; Kuan G; Harris E
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463967
[TBL] [Abstract][Full Text] [Related]
3. Differences in Transmission and Disease Severity Between 2 Successive Waves of Chikungunya.
Gordon A; Gresh L; Ojeda S; Chowell G; Gonzalez K; Sanchez N; Saborio S; Mercado JC; Kuan G; Balmaseda A; Harris E
Clin Infect Dis; 2018 Nov; 67(11):1760-1767. PubMed ID: 29697796
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence, spatial dispersion and factors associated with flavivirus and chikungunha infection in a risk area: a population-based seroprevalence study in Brazil.
Barreto FKA; Alencar CH; Araújo FMC; Oliveira RMAB; Cavalcante JW; Lemos DRQ; Farias LABG; Boriz ILF; Medeiros LQ; Melo MNP; Miyajima F; Siqueira AM; Freitas ARR; Cavalcanti LPG
BMC Infect Dis; 2020 Nov; 20(1):881. PubMed ID: 33234110
[TBL] [Abstract][Full Text] [Related]
5. Use of Household Cluster Investigations to Identify Factors Associated with Chikungunya Virus Infection and Frequency of Case Reporting in Puerto Rico.
Bloch D; Roth NM; Caraballo EV; Muñoz-Jordan J; Hunsperger E; Rivera A; Pérez-Padilla J; Rivera Garcia B; Sharp TM
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005075. PubMed ID: 27764085
[TBL] [Abstract][Full Text] [Related]
6. Low chikungunya virus seroprevalence two years after emergence in Fiji.
Aubry M; Kama M; Henderson AD; Teissier A; Vanhomwegen J; Mariteragi-Helle T; Paoaafaite T; Manuguerra JC; Christi K; Watson CH; Lau CL; Kucharski AJ; Cao-Lormeau VM
Int J Infect Dis; 2020 Jan; 90():223-225. PubMed ID: 31689529
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Chikungunya virus and living conditions in Feira de Santana, Bahia-Brazil.
Teixeira MG; Skalinski LM; Paixão ES; Costa MDCN; Barreto FR; Campos GS; Sardi SI; Carvalho RH; Natividade M; Itaparica M; Dias JP; Trindade SC; Teixeira BP; Morato V; Santana EB; Goes CB; Silva NSJ; Santos CAST; Rodrigues LC; Whitworth J
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009289. PubMed ID: 33878115
[TBL] [Abstract][Full Text] [Related]
8. Low Seroprevalence Indicates Vulnerability of Eastern and Central Sudan to Infection with Chikungunya Virus.
Adam A; Seidahmed OM; Weber C; Schnierle B; Schmidt-Chanasit J; Reiche S; Jassoy C
Vector Borne Zoonotic Dis; 2016 Apr; 16(4):290-1. PubMed ID: 26974266
[TBL] [Abstract][Full Text] [Related]
9. Chikungunya Virus Sequences Across the First Epidemic in Nicaragua, 2014-2015.
Wang C; Saborio S; Gresh L; Eswarappa M; Wu D; Fire A; Parameswaran P; Balmaseda A; Harris E
Am J Trop Med Hyg; 2016 Feb; 94(2):400-3. PubMed ID: 26643533
[TBL] [Abstract][Full Text] [Related]
10. [Chikungunya seroprevalence and clinical case rate in Nicaragua, 2014-2015].
;
Rev Panam Salud Publica; 2017 Aug; 41():e59. PubMed ID: 28902272
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of chikungunya virus infection in children from India during 2009-2010: A cross sectional observational study.
Raghavendhar BS; Ray P; Ratagiri VH; Sharma BS; Kabra SK; Lodha R
J Med Virol; 2016 Jun; 88(6):923-30. PubMed ID: 26581026
[TBL] [Abstract][Full Text] [Related]
12. Evidence of Chikungunya virus seroprevalence in Myanmar among dengue-suspected patients and healthy volunteers in 2013, 2015, and 2018.
Luvai EAC; Kyaw AK; Sabin NS; Yu F; Hmone SW; Thant KZ; Inoue S; Morita K; Ngwe Tun MM
PLoS Negl Trop Dis; 2021 Dec; 15(12):e0009961. PubMed ID: 34851949
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Chikungunya Virus after Its Emergence in Brazil.
Dias JP; Costa MDCN; Campos GS; Paixão ES; Natividade MS; Barreto FR; Itaparica MSC; Goes C; Oliveira FLS; Santana EB; Silva NSJ; Brito CAA; Rodrigues LC; Sardi SI; Saavedra RC; Teixeira MG
Emerg Infect Dis; 2018 Apr; 24(4):617-624. PubMed ID: 29553317
[TBL] [Abstract][Full Text] [Related]
14. Use of Bead-Based Serologic Assay to Evaluate Chikungunya Virus Epidemic, Haiti.
Rogier EW; Moss DM; Mace KE; Chang M; Jean SE; Bullard SM; Lammie PJ; Lemoine JF; Udhayakumar V
Emerg Infect Dis; 2018 Jun; 24(6):995-1001. PubMed ID: 29774861
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of antibodies against chikungunya virus in Singapore resident adult population.
Ang LW; Kam YW; Lin C; Krishnan PU; Tay J; Ng LC; James L; Lee VJM; Goh KT; Ng LFP; Lin RTP
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006163. PubMed ID: 29281644
[TBL] [Abstract][Full Text] [Related]
16. High seroprevalence of chikungunya virus antibodies among pregnant women living in an urban area in Benin, West Africa.
Bacci A; Marchi S; Fievet N; Massougbodji A; Perrin RX; Chippaux JP; Sambri V; Landini MP; Varani S; Rossini G
Am J Trop Med Hyg; 2015 Jun; 92(6):1133-6. PubMed ID: 25940198
[TBL] [Abstract][Full Text] [Related]
17. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
Yoon IK; Alera MT; Lago CB; Tac-An IA; Villa D; Fernandez S; Thaisomboonsuk B; Klungthong C; Levy JW; Velasco JM; Roque VG; Salje H; Macareo LR; Hermann LL; Nisalak A; Srikiatkhachorn A
PLoS Negl Trop Dis; 2015 May; 9(5):e0003764. PubMed ID: 25951202
[TBL] [Abstract][Full Text] [Related]
18. Differing epidemiological dynamics of Chikungunya virus in the Americas during the 2014-2015 epidemic.
Tan Y; Pickett BE; Shrivastava S; Gresh L; Balmaseda A; Amedeo P; Hu L; Puri V; Fedorova NB; Halpin RA; LaPointe MP; Cone MR; Heberlein-Larson L; Kramer LD; Ciota AT; Gordon A; Shabman RS; Das SR; Harris E
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006670. PubMed ID: 30059496
[TBL] [Abstract][Full Text] [Related]
19. Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.
Olajiga OM; Adesoye OE; Emilolorun AP; Adeyemi AJ; Adeyefa EO; Aderibigbe IA; Adejumo SA; Adebimpe WO; Opaleye OO; Sule WF; Oluwayelu DO
Immunol Invest; 2017 Aug; 46(6):552-565. PubMed ID: 28742401
[TBL] [Abstract][Full Text] [Related]
20. Evidence of previous but not current transmission of chikungunya virus in southern and central Vietnam: Results from a systematic review and a seroprevalence study in four locations.
Quan TM; Phuong HT; Vy NHT; Thanh NTL; Lien NTN; Hong TTK; Dung PN; Chau NVV; Boni MF; Clapham HE
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006246. PubMed ID: 29425199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
